These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15392542)

  • 21. [Tuberculostatic effects of streptomycin, PAS, PAS-propylester and thiomycid in animal experimentation].
    EIDUS L; SOLYMOSS B; SZABO I
    Kiserl Orvostud; 1951; 3(5):369-73. PubMed ID: 14889686
    [No Abstract]   [Full Text] [Related]  

  • 22. [Techniques of chromatography and determination of para-aminosalicylic acid and its derivatives in biological fluids].
    GUILLAUME J; PETIT H
    Ann Inst Pasteur Lille; 1958-1959; 10():73-88. PubMed ID: 13963408
    [No Abstract]   [Full Text] [Related]  

  • 23. [Local therapeutic use of tuberculostatic solutions in tuberculosis of the kidneys and bladder].
    RAABE S
    Z Urol; 1952; 45(Suppl):60-79. PubMed ID: 12995853
    [No Abstract]   [Full Text] [Related]  

  • 24. An in vitro study of the synergistic action of aureomycin and para-amino salicylic acid against some pathogenic bacteria.
    SIRSI M; KALE LS
    Indian J Med Res; 1951 Jul; 39(3):397-402. PubMed ID: 14937755
    [No Abstract]   [Full Text] [Related]  

  • 25. [In vitro study of P.A.S].
    VERIN
    J Med Bord; 1951 Apr; 128(4):509-10. PubMed ID: 14832565
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bacteriological studies on the resistance of Mycobacterium tuberculosis against streptomycin and other tuberculostatic drugs].
    POTHMANN FJ
    Ergeb Hyg Bakteriol Immunitatsforsch Exp Ther; 1955; 29():248-393. PubMed ID: 13241442
    [No Abstract]   [Full Text] [Related]  

  • 27. [Results of the treatment of pleural empyema with para-aminosalicylic acid (PAS-cilag) and with combined para-aminosalicylic acid and streptomycin].
    ZEBROWSKI T
    Gruzlica (1926); 1950; 18(3-4):380-91. PubMed ID: 14823448
    [No Abstract]   [Full Text] [Related]  

  • 28. [Stability of PAS resistance in vitro and in vivo].
    NITTI V; DE FRANCISCIS V; CANTARELLA R
    Boll Soc Ital Biol Sper; 1950 Jul; 26(7):1068-70. PubMed ID: 14811969
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of tuberculosis with para-aminosalicylic acid; treatment of specific thoracic empyema with para-aminosalicylic acid].
    VIRSIK K
    Bratisl Lek Listy; 1951; 31(1-2):132-6. PubMed ID: 14848351
    [No Abstract]   [Full Text] [Related]  

  • 30. [Combined tuberculostatic therapy of laryngopulmonary tuberculosis].
    PRIETZEL F
    Wien Med Wochenschr; 1954 Dec; 104(51-52):1013-20. PubMed ID: 14359965
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hypersensitivity to tuberculostatic drugs in the treatment of pulmonary tuberculosis; in reference to a case].
    DE ALEMQUER M; LISBOA PE
    J Med (Oporto); 1956 Apr; 29(689):753-60. PubMed ID: 13318813
    [No Abstract]   [Full Text] [Related]  

  • 32. Results in treating tuberculous empyemata with para-aminosalicylic acid or with combined administration of para-aminosalicylic acid and streptomycin.
    ZEBROWSKI T
    Acta Tuberc Scand; 1952; 26(1-2):61-5. PubMed ID: 14952344
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of tuberculostatic substances on purine enzymes. III. Experience with uricase from rat liver].
    DI FONZO M
    Boll Soc Ital Biol Sper; 1952 May; 28(5):961-2. PubMed ID: 13018572
    [No Abstract]   [Full Text] [Related]  

  • 34. A five-year assessment of patients in a controlled trial of streptomycin, para-aminosalicylic acid, and streptomycin plus para-aminosalicylic acid, in pulmonary tuberculosis.
    FOX W; SUTHERLAND I
    Q J Med; 1956 Apr; 25(98):221-43. PubMed ID: 13323251
    [No Abstract]   [Full Text] [Related]  

  • 35. [Stability of PAS resistance in vitro and in vivo].
    NITTI V; DE FRANCISCIS V; CANTARELLA R
    Arch Tisiol Mal Appar Respir; 1950 May; 5(5):444-52. PubMed ID: 14777692
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of PAS in vitro on the erythrosedimentatic rate].
    GUALLAR SEGARRA J; ROLDAN SALINAS H; POMARES VR
    Med Esp; 1951 Feb; 25(143):105-8. PubMed ID: 14842428
    [No Abstract]   [Full Text] [Related]  

  • 37. [Spectrophotometry of para-aminosalicylic acid].
    PEREIRA FORJAZ
    An Azevedos; 1949; 1(2):50-5. PubMed ID: 18130195
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of PAS on Brucella melitensis in vitro].
    ARU L; NAVONI C
    Rass Med Sarda; 1952; 54(7-8):222-6. PubMed ID: 13014347
    [No Abstract]   [Full Text] [Related]  

  • 39. [A new derivative of PAS, phenyl paraaminosalicylate or FR7; tuberculostatic activity in vitro and in the mouse].
    AMERICANO FREIRE S; RIST N; GRUMBACH F
    Ann Inst Pasteur (Paris); 1951 Oct; 81(4):407-23. PubMed ID: 14894908
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum para-aminosalicylic acid following oral ingestion in children.
    SODERHJELM L
    Tex Rep Biol Med; 1949; 7(3):471-9. PubMed ID: 18143811
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.